| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.3M | +12.9% | +905.4% |
| R&D Expense | $2.2M | +19.4% | -8.3% |
| SG&A Expense | $9.4M | +6.2% | -41.5% |
| Operating Income | $1.6M | +7.7% | +107.9% |
| Net Income | -$274K | -234.3% | +98.8% |
| EPS (Basic) | -$0.03 | -250.0% | +93.9% |
| EPS (Diluted) | -$0.03 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $21.1M | +37.0% | -8.1% |
| Accounts Receivable | $7.0M | -23.3% | — |
| Inventory | $2.3M | -8.6% | -10.8% |
| Current Assets | $36.3M | -1.4% | +28.7% |
| Total Assets | $40.9M | +4.6% | +24.2% |
| Current Liabilities | $28.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$13.0M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | -$12.2M | — | — |
| Free Cash Flow | -$13.0M | — | — |
| -250.0% |
| +93.9% |
| -1.1% |
| +37.5% |
| Long-term Debt | $21.6M | -12.0% | -50.1% |
| Total Liabilities | $57.9M | +2.4% | -13.5% |
| Stockholders' Equity | -$17.0M | +2.5% | +50.0% |